Quando nasce il vaccino contro l'Epatite B?
Riferimenti
- Schmeck Jr. VACCINE FOR HEPATITIS B, JUDGED HIGHLY EFFECTIVE, IS APPROVED BY F.D.A. New York Times Nov. 17, 1981.
- Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations. Wkly Epidemiol Rec July 2017; 92(27):369-92.
- Krugman S. Hepatitis virus vaccines: present status. Yale J Biol Med Aug 1982.
- US Centers for Disease Control and Prevention. Recommendation of the Immunization Practices Advisory Committee (ACIP) Inactivated Hepatitis B Virus Vaccine. MMWR Jun. 25, 1982; 31(24):317-22.
- Boffey PM. U.S. APPROVES A GENETICALLY ALTERED VACCINE. New York Times Jul. 24, 1986.
- Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Hepatitis B. 13th ed. Centers for Disease Control (CDC) Aug. 18, 2021.
- US Centers for Disease Control and Prevention. Recommendation of the Immunization Practices Advisory Committee (ACIP) Inactivated Hepatitis B Virus Vaccine. MMWR Jun. 25, 1982; 31(24): 317-22.
- US Centers for Disease Control and Prevention. Recommendations of the Immunization Practices Advisory Committee Update on Hepatitis B Prevention. MMWR June 19, 1987; 36(23):353-366.
- US Centers for Disease Control and Prevention. Recommendations of the Immunization Practices Advisory Committee Update on Hepatitis B Prevention. MMWR June 19, 1987; 36(23):353-366.
- US Centers for Disease Control and Prevention. Summary of Bases for Approval - Engerix - B. Jan. 28, 2023.
- US Centers for Disease Control and Prevention. Hepatitis B Virus: A Comprehensive Strategy for Eliminating Transmission in the United States Through Universal Childhood Vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Nov. 22, 1991.
- US Centers for Disease Control and Prevention. Protection against Viral Hepatitis Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Feb. 9, 1990.
- US Centers for Disease Control and Prevention. Hepatitis B Virus: A Comprehensive Strategy for Eliminating Transmission in the United States Through Universal Childhood Vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Nov. 22, 1991.
- Conis E. “Do We Really Need Hepatitis B on the Second Day of Life?” Vaccination Mandates and Shifting Representations of Hepatitis B. J Med Humanit June 2011; 32(2): 155–166.
- US Centers for Disease Control and Prevention. Hepatitis B Virus: A Comprehensive Strategy for Eliminating Transmission in the United States Through Universal Childhood Vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Nov. 22, 1991.
- US Centers for Disease Control and Prevention. Hepatitis B Virus: A Comprehensive Strategy for Eliminating Transmission in the United States Through Universal Childhood Vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Nov. 22, 1991.
- US Centers for Disease Control and Prevention. Hepatitis B Virus: A Comprehensive Strategy for Eliminating Transmission in the United States Through Universal Childhood Vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Nov. 22, 1991.
- US Food and Drug Administration. Summary of Basis for Approval – Recombivax HB.
- US Food and Drug Administration. Summary of Bases for Approval – Engerix-B.
- US Centers for Disease Control and Prevention. Notice to Readers: Thimerosal in Vaccines: A Joint Statement of the American Academy of Pediatrics and the Public Health Service. MMWR Jul. 9, 1999; 48(26):563-565.
- US Centers for Disease Control and Prevention. Notice to Readers: Thimerosal in Vaccines: A Joint Statement of the American Academy of Pediatrics and the Public Health Service. MMWR Jul. 9, 1999; 48(26):563-565.
- US Centers for Disease Control and Prevention. August 27, 1999 Approval Letter - Recombivax HB. August 27, 1999.
- US Centers for Disease Control and Prevention. January 30, 2007 Approval Letter - Engerix-B. Jan 30 2007.
- US Centers for Disease Control and Prevention. Notice to Readers: Availability of Hepatitis B Vaccine That Does Not Contain Thimerosal as a Preservative. MMWR Sept. 10, 1999; 48(35):780-782.
- https://it.wikipedia.org/wiki/GlaxoSmithKline
- https://www.treccani.it/enciclopedia/tangentopoli_%28Enciclopedia-Italiana%29/
- https://www.gazzettaufficiale.it/eli/id/1991/06/01/091G0201/sg
- https://it.wikipedia.org/wiki/Tina_Anselmi
- https://www.lapresse.it/cronaca/2016/02/19/sanita-25-anni-di-scandali-da-poggiolini-al-caso-rizzi/
- https://www.ilfattoquotidiano.it/2012/04/12/lorenzo-poggiolini-condannati-cassazione-dovranno-pagare-milioni-testa-allo-stato/204037/
- https://it.finance.yahoo.com/notizie/vaccini-tangenti-scandalo-150713160.html
NOTA IMPORTANTE: Corvelva invita a informarsi in modo approfondito leggendo tutte le sezioni e link, oltre che i foglietti illustrativi e schede tecniche dei prodotti del produttore, e a parlare con uno o più professionisti di fiducia prima di decidere di vaccinare se stessi o il proprio bambino. Queste informazioni sono solo a scopo informativo e non sono da intendersi come consigli medici.